THE EBMT RISK SCORE CAN PREDICT THE OUTCOME AFTER ALLOGENEIC HEMATOPOIETC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA AMONG EGYPTIAN PATIENTS

被引：0
|
作者：
Desoukey, S. [1 ]
Fahmy, O. [1 ,2 ]
Kamel, H. [3 ,4 ]
Galal, A. [5 ]
Messner, H. [5 ]
机构：
[1] Cairo Univ, Kasr Al Ainy Sch Med, Internal Med, Cairo, Egypt
[2] Nasser Inst Hosp, Cairo, Egypt
[3] Natl Canc Inst, Hematol & Oncol, Cairo, Egypt
[4] Nasser Inst Hosp, Stem Cell Transplantat, Cairo, Egypt
[5] Princess Margaret Hosp, Hematol & Oncol, Toronto, ON M4X 1K9, Canada
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1515
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [31] Outcome of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukaemia
    Devillier, R.
    Crocchiolo, R.
    Etienne, A.
    Prebet, T.
    Charbonnier, A.
    Fuerst, S.
    El Cheikh, J.
    D'Incan, E.
    Rey, J.
    Faucher, C.
    Blaise, D.
    Vey, N.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S100 - S100
  • [32] The Impact of Allogeneic Hematopoietic Stem-Cell Transplantation on Outcome of the Patients with Intermediate-Risk Acute Myeloid Leukemia
    Wang, Ying
    Wei, Hui
    Lin, Dong
    Zhou, Chunlin
    Liu, Bingcheng
    Qiu, Shaowei
    Gong, Benfa
    Zhang, Guangji
    Liu, Kaiqi
    Wei, Shuning
    Liu, Yuntao
    Gong, Xiaoyuan
    Zhao, Xingli
    Li, Yan
    Gu, Runxia
    Mi, Yingchang
    Wang, Jianxiang
    BLOOD, 2016, 128 (22)
  • [33] The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT
    Poiani, Monica
    Labopin, Myriam
    Beelen, Dietrich W.
    Tischer, Johanna
    Finke, Juergen
    Brecht, Arne
    Forcade, Edouard
    Ganser, Arnold
    Passweg, Jakob R.
    Labussiere-Wallet, Helene
    Yakoub-Agha, Ibrahim
    Schaefer-Eckart, Kerstin
    Kroeger, Nicolaus
    Lioure, Bruno
    Ruggeri, Annalisa
    Esteve, Jordi
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD, 2018, 132
  • [34] Acute myeloid leukemia of donor cell origin after allogeneic stem cell transplantation in a patient with acute myeloid leukemia
    Hindilerden, F.
    Kantarcioglu, B.
    Guvenc, S.
    Goksoy, H. S.
    Buyukdogan, M.
    Ozcelik, T.
    Kucukkaya, R. Diz
    Arat, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5610 - 5610
  • [35] Continuously Improving Outcome over Time after Second Allogeneic Stem Cell Transplantation in Relapsed Acute Myeloid Leukemia - a Retrospective Analysis of 1540 Patients on Behalf of the Acute Leukemia Working Party of EBMT
    Schmaelter, Ann-Kristin
    Ngoya, Maud
    Finke, Juergen
    Kroeger, Nicolaus
    Stoelzel, Friedrich
    Stelljes, Matthias
    Valerius, Thomas
    Tischer, Johanna
    Schroeder, Thomas
    Dreger, Peter
    Blau, Igor Wolfgang
    Savani, Bipin
    Giebel, Sebastian
    Esteve, Jordi
    Bazarbachi, Ali
    Nagler, Arnon
    Schmid, Christoph
    Ciceri, Fabio
    Mohty, Mohamad
    BLOOD, 2022, 140 : 4799 - 4801
  • [36] Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
    Middeke, Jan M.
    Fang, Min
    Cornelissen, Jan J.
    Mohr, Brigitte
    Appelbaum, Frederick R.
    Stadler, Michael
    Sanz, Jaime
    Baurmann, Herrad
    Bug, Gesine
    Schaefer-Eckart, Kerstin
    Hegenbart, Ute
    Bochtler, Tilmann
    Roellig, Christoph
    Stoelzel, Friedrich
    Walter, Roland B.
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Loewenberg, Bob
    Schetelig, Johannes
    BLOOD, 2014, 123 (19) : 2960 - 2967
  • [37] OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER CONDITIONING WITH BUSULFAN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE
    Ayas, Mouhab
    Belgaumi, Assim
    Al-Seraihy, Amal
    Al-Jefri, Abdullah
    Al-Ahmari, Ali
    Al-Mahr, Mohammed
    Khairy, Ashraf
    Markiz, Samer
    El-Soth, Hassan
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 816 - 816
  • [38] Outcome Of Patients With Abnl(17p) Acute Myeloid Leukemia After Allogeneic Hematopoietic Ste Cell Transplantation
    Middeke, Jan Moritz
    Fang, Min
    Cornelissen, Jan
    Appelbaum, Frederick R.
    Mohr, Brigitte
    Stadler, Michael
    Sanz, Miguel
    Baurmann, Herrad
    Bug, Gesine
    Schaefer-Eckart, Kerstin
    Hegenbart, Ute
    Bochtler, Tilmann
    Stoelzel, Friedrich
    Walter, Roland B.
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Loewenberg, Bob
    Schetelig, Johannes
    BLOOD, 2013, 122 (21)
  • [39] Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. risk factors at diagnosis can predict the outcome
    Candoni, A
    Sperotto, A
    Tomadini, V
    Filì, C
    Damiani, D
    Fanin, R
    LEUKEMIA & LYMPHOMA, 2003, 44 (06) : 1083 - 1085
  • [40] Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation
    Kurosawa, Shuhei
    Toya, Takashi
    Kishida, Yuya
    Nagata, Akihito
    Yamada, Yuta
    Konishi, Tatsuya
    Kaito, Satoshi
    Yoshifuji, Kota
    Matsuyama, Naoki
    Shirane, Shuichi
    Uchida, Tomoyuki
    Inamoto, Kyoko
    Igarashi, Aiko
    Najima, Yuho
    Muto, Hideharu
    Kobayashi, Takeshi
    Doki, Noriko
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 3006 - 3009
12345